JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online July 17, 2009, 10.2967/jnumed.109.064634
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.109.064634v1
50/8/1385-a    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dore, F.
Right arrow Articles by Filippi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dore, F.
Right arrow Articles by Filippi, L.
Journal of Nuclear Medicine Vol. 50 No. 8 1385
© 2009 by Society of Nuclear Medicine
doi: 10.2967/jnumed.109.064634

Reply: Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw

Franca Dore and Luca Filippi

Azienda Ospedaliero-Universitaria
Trieste, Italy

REPLY: We thank Fabbricini and colleagues for their letter and appreciate their comments on our study (1).

The aim of our study was more to assess the possible clinical utility of hybrid SPECT/CT for 99mTc-methylene diphosphonate (MDP) imaging of osteonecrosis of the jaw than to differentiate between metastasis and osteonecrosis of the jaw.

Because of the well-known lack of specificity of bone scanning, all 15 patients underwent an accurate clinical evaluation, which, in every case, supported the suspicion of osteonecrosis of the jaw.

Fourteen patients had exposed bone (8 at the time of the scintigraphic study), and among these 14, 4 had multiple myeloma. Biopsy excluded metastatic involvement of the jaw and confirmed osteonecrosis of the jaw in all cases.

The hybrid SPECT/CT findings correlated with the clinical and histologic findings.

The 4 patients with multiple myeloma did not undergo bone scanning for staging, since 99mTc-MDP imaging is known to have poor sensitivity in this disease except when used to evaluate therapeutic response or to detect early osteosclerotic reactions.

SPECT/CT increased the accuracy of conventional imaging by allowing differentiation between the osteonecrotic core and viable bone in 8 patients. SPECT/CT also provided important information for treatment planning. Catalano et al. (2) showed that in differentiating osteonecrosis of the jaw from myeloma osteolysis, an imaging technique such as sestamibi scintigraphy, with a tracer taken up by neoplastic cells and not by inflammatory ones, may be more helpful than an imaging procedure such as 18F-FDG PET, with a tracer taken up also by inflammation.

They raise the interesting question of whether 99mTc-sestamibi SPECT/CT coupled with 99mTc-MDP SPECT/CT is as accurate as 99mTc-sestamibi SPECT coupled with 18F-FDG PET. Regarding this question, we fully agree with the paper by Pazianas et al. (3), who suggested that because our group obtained satisfying results using a basilar SPECT/CT technology, better results might be achieved using hybrid systems with higher resolution and greater diagnostic capability.

FOOTNOTES

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

References

  1. Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med. 2009;50:30–35.[Abstract/Free Full Text]
  2. Catalano L, Del Vecchio S, Petruzziello F, et al. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol. 2007;86:415–423.[CrossRef][Medline]
  3. Pazianas M, Russell RG, Fogelman I. Osteonecrosis of the jaw: more heat than light. J Nucl Med. 2009;50:6–7.[Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.109.064634v1
50/8/1385-a    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dore, F.
Right arrow Articles by Filippi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dore, F.
Right arrow Articles by Filippi, L.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE